This finding suggests public health efforts will have to address the treatment barriers these men face – like poverty or homophobia – to meet the nation’s goal of ending the HIV epidemic by 2030.
Academic rigour, journalistic flair
Articles on Public health
Displaying 501 - 520 of 2151 articles
HIV services must be comprehensive to ensure that people take their medication as prescribed and avoid onward transmission of the virus.
Even before the advent of COVID-19, donors had begun to exit HIV programmes with increasing frequency.
To be effective, vaccine formulas need to cover all emergent strains. But there are still plenty of unknowns.
Burkina Faso is one of the poorest countries in the world. Financial barriers still prevent many families from getting the health services they need.
Manufacturing is just one part of the vaccine ecosystem. It’s the health system that delivers vaccines and people must be willing to take them.
The current spate of travel bans is rather hasty and irrational given that we know that the variant is in several countries already.
Two film crews comprised of Latino and Black cinematic arts graduate students made short films to counter vaccine fears in both communities.
Stigma and criminalisation of same-sex relationships makes it difficult for transgender women and men who have sex with men to seek preventive services. This compounds their risk for HIV infection.
It is urgent and overdue to implement PrEP in pregnancy and during breastfeeding. Failure to do so allows ongoing avoidable HIV infection among women in South Africa and their infants.
Adolescent girls and young women aged 15 to 24 accounted for 25% of new infections, while making up only 10% of the population.
The world needs to learn to live with the virus. And governments must follow the science and don’t distort it for political expediency.
There’s a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants
Skin lighteners are being used more than ever before, especially in urban areas and among men.
The quest to find treatment for COVID-19, and the uncertainty surrounding the clinical outcome, necessitates the use of antibiotics in the treatment package.
The need of the moment is for low- and middle-income countries to improve their own manufacturing capabilities.
Insulin and oral medicines for diabetes are mostly not available at the recommended level in the African region.
It has long been clear that some countries have drug policies that cause harm and violate human rights.
South Africa has a stringent pharmaceutical regulatory framework. But this framework is not backed by a strong implementation strategy.
Vaccination uptake is influenced by many factors and carries a variety of meanings – social, political, economic, ideological, moral as well as biological.
Afrigen will be a technology transfer and training hub: it shares technology and develops skills specifically around how to produce a safe, effective and affordable mRNA vaccine.
Top contributors
-
Emeritus Professor in Public Health, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Research Scientist, African Population and Health Research Center
-
Executive Secretary, Nigerian Academy of Science
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Medical scientist, National Institute for Communicable Diseases
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Distinguished Professor in the Department of Medicine and Director, The Centre for Medical Ethics & Law, Stellenbosch University
-
Fellow, Nigerian Academy of Science
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Chief Research Officer, Kenya Medical Research Institute
-
Vice Chancellor, University of Global Health Equity
-
Dornsife Endowed Professor of Global Health, Drexel University
